CTY · Ratios · TradingHolo

Markets › United States › NAS › CTY

City Therapeutics, Inc.

NAS:CTYHealth Technologynasdaq_composite

$21.46−4.20%At closeAt close · Tue 20 Oct · ≈ AED 78.81 · Market cap $1.08B

🔔 Alert▶ Test a strategy

Ratio	FY2024	FY2025
Gross margin	84.7%	91.4%
Operating margin	−1,047.2%	−441.8%
Net margin	−1,002.0%	−431.4%
EBITDA margin	−1,031.9%	−433.2%
Return on equity	94.6%	69.1%
Return on assets	−19.2%	−39.1%
Return on capital employed	−23.3%	−53.6%
Debt / equity	−5.7×	−2.5×
Debt / assets	114.8%	141.4%
Interest coverage	−64.9×	−26.5×
Current ratio	6.2×	3.1×
Quick ratio	6.2×	3.1×
Cash ratio	6.1×	3.0×
Asset turnover	0.0×	0.1×
Receivables turnover	2.1×	11.2×
Dividend payout	0.0%	0.0%

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ